• Professor at Dalian Medical University, Shanxi Medical University, and East China Normal University.
• Co-Editor-in-Chief of M&TOD
• Cheung Kong Scholar Distinguished Professor and Recipient of the National Science Fund for Distinguished Young Scholars
• The World’s Top 2% Scientist; Highly Cited Researcher
• H-index: 62
Topic: HSD17B13: A New Therapeutic Target for Fatty Liver Disease

• Azienda Ospedaliero-Universitaria di Modena, Ospedale Civile di Baggiovara, Modena, Italy (- 2023).
• Editor-in-Chief & Founding Editor of M&TOD
• The World’s Top 2% Scientist
• H-index: 67
Topic: Sex Differences in MASLD

• Centre for Digestive Discases, Lausanne, Switzerland.
• Co-founder of the International Liver Cancer Association (ILCA)
• The World’s Top 2% Scientist
• H-index: 77
Topic: How to Think MASLD-HCC Management Progressively?

• Director, Renovascular Disease Research Laboratory, Mayo Clinic.
• The World’s Top 2% Scientist
• H-index: 90
Topic: Obesity Attenuates Cardiovascular Protection

• Chief Physician, Infectious Diseases and Hepatology Center, The First Affiliated Hospital of Wenzhou Medical University.
• Editorial Board Member of M&TOD
• The World’s Top 2% Scientist; Highly Cited Researcher
• H-index: 67
Topic: Novel Agents to Treat MASLD

• Director, Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
• Editorial Board Member of M&TOD
• The World’s Top 2% Scientist; Highly Cited Researcher
• H-index: 78
Topic: Chinese guidelines for MAFLD 2025

• Chair of Endocrinology & Metabolism, University of Southampton
• Honorary Editor-in-Chief of M&TOD
• Highly Cited Researcher
• H-index: 94
Topic: MASLD as a Multisystem Disease?

• Professor and Deputy Director, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences
• Director, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
• Cheung Kong Scholar Distinguished Professor and Recipient of the National Science Fund for Distinguished Young Scholars
• H-index: 54
Topic: Lactate Shuttle in Glucose Homeostasis

• Director, Department of Gastroenterology, Southwest Hospital, Army Medical University; Director, Research Institute of Digestive Diseases of the PLA
• Director, Center for Metabolic-Associated Fatty Liver Disease Research and Center for Cholestatic Liver Diseases
• Recipient of the National Science Fund for Distinguished Young Scholars and the Excellent Young Scientists Fund of China
Topic: Clinical Precision Subtyping of MASLD

• Robert W Storr Chair of Hepatic Medicine, Sydney Medical School Director, Storr Liver Centre, The Westmead Institute for Medical Research and Head, Department of Gastroenterology & Hepatology, Westmead Hospital and Sydney West Local Health District, Australia.
• The World’s Top 2% Scientist; Highly Cited Researcher
• H-index: 120
Topic: Public policy and MAFLD